Through multi-omics characterization and experimental validation, we have established the clinical significance of G6PC1 in HCC and elucidated its potential roles in HCC pathogenesis, including oncogenic mechanisms, metabolic reprogramming, and immune regulatory role. The gene discussed is G6PC1; the disease is hepatocellular carcinoma.